ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1988

Advancing Vascular Assessment: Combining NIRS-VOT and Ultrasound-Based Brachial Artery Diameter for Improved Diagnostics in Healthy Controls and APS

Soongho Park1, Julie Mathew1, Sharon Osgood2, Claudia Gomez1, Eric Leifer1, Ecem Sevim1 and Yogendra Kanthi3, 1NIH, Bethesda, 2NHLBI/NIH, Bethesda, 3National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Meeting: ACR Convergence 2025

Keywords: Decision analysis, Measurement, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1972–1989) Measures & Measurement of Healthcare Quality Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Near-Infrared Spectroscopy combined with Vascular Occlusion Test (NIRS-VOT) is a non-invasive diagnostic method for assessing microvascular function. However, its diagnostic accuracy is often limited by inter-individual variability, particularly anatomical differences in vascular structure, such as brachial artery diameter (BAD). Since BAD significantly influences blood flow and may affect NIRS-VOT readings, we propose incorporating BAD as a reference parameter to standardize NIRS-VOT results and improve diagnostic reliability. This approach is particularly relevant in diseases like Antiphospholipid Syndrome (APS), a rare autoimmune disorder characterized by vascular dysfunction.

Methods: We applied this combined method to a cohort of 10 healthy controls (HCs) and 9 patients with APS. Brachial artery diameter was measured using ultrasound imaging, and NIRS-VOT was performed to assess tissue oxygen saturation (StO₂) parameters during vascular occlusion and reperfusion. We conducted correlation analyses to evaluate the relationship between BAD and NIRS-VOT parameters and performed logistic regression to examine whether including BAD improved classification between HCs and APS patients. Multiple statistical analyses were used to identify independent predictors of key NIRS-VOT outcomes.

Results: Our results indicate that incorporating BAD into NIRS-VOT significantly improves interpretation of hemodynamic parameters. In HCs, strong correlations were observed between BAD and NIRS-derived parameters (e.g., r = 0.95, p < 0.01), while correlations in APS patients were notably weaker, suggesting greater variability in vascular response. Both BAD and APS status emerged as significant independent predictors of key NIRS-VOT metrics. Logistic regression analysis showed that the inclusion of BAD improved classification accuracy—by at least 7.14% for baseline and minimum StO₂, and by up to 28.57% for maximum StO₂. Without BAD, the highest classification accuracy for maximum StO₂ was 78.57%, whereas including BAD increased it to 92.86%.

Conclusion: This study demonstrates the feasibility and utility of combining NIRS-VOT with ultrasound-derived BAD measurements for assessing microvascular function. To our knowledge, this is the first study to explore the interplay between conduit artery structure and NIRS-based functional assessments in this way. The integration of BAD into NIRS-VOT significantly enhances diagnostic accuracy, reduces inter-individual variability, and offers a more robust framework for evaluating vascular health. This approach shows promise not only for identifying vascular dysfunction in rare conditions such as APS but may also be applicable to other conduit arteries like the femoral artery, broadening the method’s potential clinical applications.

Supporting image 1Figure 1. (a) Experimental setup combining a linear ultrasound probe on the upper arm to measure brachial artery diameter and a NIRS probe on the thenar for vascular occlusion testing (VOT). (b) Schematic of NIRS-derived tissue oxygen saturation (StO2) during VOT, including Baseline, Occlusion, and Reperfusion phases. Key parameters analyzed: baseline, minimum, maximum, resaturation time (tR), area under the curve (AUC), and hyperemic recovery time (tA).


Disclosures: S. Park: None; J. Mathew: None; S. Osgood: None; C. Gomez: None; E. Leifer: None; E. Sevim: None; Y. Kanthi: None.

To cite this abstract in AMA style:

Park S, Mathew J, Osgood S, Gomez C, Leifer E, Sevim E, Kanthi Y. Advancing Vascular Assessment: Combining NIRS-VOT and Ultrasound-Based Brachial Artery Diameter for Improved Diagnostics in Healthy Controls and APS [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/advancing-vascular-assessment-combining-nirs-vot-and-ultrasound-based-brachial-artery-diameter-for-improved-diagnostics-in-healthy-controls-and-aps/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/advancing-vascular-assessment-combining-nirs-vot-and-ultrasound-based-brachial-artery-diameter-for-improved-diagnostics-in-healthy-controls-and-aps/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology